Dr Rowan Chlebowski - Harbor-UCLA Medical Center, Los Angeles, US
ASCO 2009: Rowan T. Chlebowski, MD, PhD - Harbor-UCLA Medical Center - Los Angeles: Menopausal Hormone Therapy with Estrogen and Progestin Linked to Increased Risk of Death
from Non-Small Cell Lung Cancer
Researchers have shown that use of hormone therapy with estrogen plus progestin increases the risk of dying from
non-small cell lung cancer (NSCLC) in women with the disease. Lung cancer is the leading cause of cancer death
in U.S. women.
